Accera Spins Off Neuera Pharmaceuticals

Broomfield, Colorado-based Accera, a developer of treatments for central nervous sytem diseases, said Wednesday that it has spun off a new firm, Neuera Pharmaceuticals, backed by $12M in a Series A financing round. According to Accera, Neuera will focus on the discovery and development of proprietary small molecule drugs, particularly around defective energy metabolism or hypometabolism. Accera said that some of its management and staff will join the new firm, and the firm's small molecule pipeline has been transferred to the new firm.